From October 1, 2022 to December 16, 2022, the company has repurchased 107,590 shares, representing 0.53% for CAD 0.07 million. With this, the company has completed the repurchase of 663,600 shares, representing 3.19% for CAD 1.06 million under the buyback announced on December 15, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 CAD | 0.00% | -1.15% | -12.24% |
Mar. 13 | Crescita Therapeutics Reports Q4 Net Loss of $0.01 Per Share | MT |
Mar. 13 | Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023. | CI |
1st Jan change | Capi. | |
---|---|---|
-12.24% | 6.12M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CTX Stock
- News Crescita Therapeutics Inc.
- Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on December 15, 2021.